Dr Reddys Laboratories RDY
NYSE RDY
$11.88 +0.00 (+0.00%)
As of: Sep 9, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Gross Profit (QoQ) (2009 - 2026)

Analysis

Dr Reddys Laboratories (RDY) Gross Profit (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.59%
Mar 31, 2026 -29.88%
Dec 31, 2025 -4.77%
Sep 30, 2025 -2.87%
Jun 30, 2025 4.10%
Mar 31, 2025 -6.05%
Dec 31, 2024 1.86%
Sep 30, 2024 2.66%
Jun 30, 2024 11.22%
Mar 31, 2024 -1.45%
Dec 31, 2023 3.79%
Sep 30, 2023 0.48%
Jun 30, 2023 2.10%
Mar 31, 2023 8.43%
Dec 31, 2022 -10.04%
Sep 30, 2022 44.70%
Jun 30, 2022 -11.77%
Mar 31, 2022 0.86%
Dec 31, 2021 0.53%
Sep 30, 2021 -9.16%